Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Dec 2024 value amounting to $1.8 million.

  • Cumberland Pharmaceuticals' Other Working Capital Changes rose 69.86% to -$178,936 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 59.46%. This contributed to the annual value of $1.8 million for FY2024, which is 52.09% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Other Working Capital Changes of $1.8 million as of FY2024, which was down 52.09% from $3.7 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Other Working Capital Changes peaked at $3.7 million during FY2023, and registered a low of -$1.9 million during FY2020.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Other Working Capital Changes value was $1.8 million (recorded in 2024), while the average stood at $1.6 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Other Working Capital Changes tumbled by 154.77% in 2020 and then spiked by 640.31% in 2023.
  • Cumberland Pharmaceuticals' Other Working Capital Changes (Yearly) stood at -$1.9 million in 2020, then rose by 27.74% to -$1.3 million in 2021, then spiked by 48.70% to -$689,260 in 2022, then skyrocketed by 640.31% to $3.7 million in 2023, then tumbled by 52.09% to $1.8 million in 2024.